v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A common stock
Class B common stock
Common Stock
Class A common stock
Common Stock
Class B common stock
Additional paid-in capital
Accumulated other comprehensive gain (loss)
Accumulated deficit
Balance (in shares) at Dec. 31, 2024       146,953,271 19,937,500      
Balance at Dec. 31, 2024 $ 215,420     $ 16 $ 2 $ 811,998 $ 45 $ (596,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon exercise of stock options (in shares)       623,834        
Common stock issued upon exercise of stock options 1,600         1,600    
Common stock issued upon vesting of restricted stock units (in shares)       358,511        
Common stock issued from direct equity offering and upon exercise of pre-funded warrants, net of fees and issuance costs (in shares)       15,625,000        
Common stock issued from direct equity offering and upon exercise of pre-funded warrants, net of fees and issuance costs 46,774         46,774    
Stock-based compensation 2,362         2,362    
Net unrealized gain (loss) on marketable securities, net of tax (53)           (53)  
Foreign currency translation 6           6  
Net loss (19,189)             (19,189)
Balance (in shares) at Mar. 31, 2025       163,560,616 19,937,500      
Balance at Mar. 31, 2025 246,920     $ 16 $ 2 862,734 (2) (615,830)
Balance (in shares) at Dec. 31, 2024       146,953,271 19,937,500      
Balance at Dec. 31, 2024 215,420     $ 16 $ 2 811,998 45 (596,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net unrealized gain (loss) on marketable securities, net of tax (107)              
Foreign currency translation 22              
Net loss (48,025)              
Balance (in shares) at Jun. 30, 2025       164,357,534 19,937,500      
Balance at Jun. 30, 2025 220,983     $ 16 $ 2 865,671 (40) (644,666)
Balance (in shares) at Mar. 31, 2025       163,560,616 19,937,500      
Balance at Mar. 31, 2025 246,920     $ 16 $ 2 862,734 (2) (615,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon exercise of stock options (in shares)       24,583        
Common stock issued upon exercise of stock options 41         41    
Common stock issued upon vesting of restricted stock units (in shares)       772,335        
Stock-based compensation 2,896         2,896    
Net unrealized gain (loss) on marketable securities, net of tax (54)           (54)  
Foreign currency translation 16           16  
Net loss (28,836)             (28,836)
Balance (in shares) at Jun. 30, 2025       164,357,534 19,937,500      
Balance at Jun. 30, 2025 220,983     $ 16 $ 2 865,671 (40) (644,666)
Balance (in shares) at Dec. 31, 2025   196,431,273 19,937,500 196,431,273 19,937,500      
Balance at Dec. 31, 2025 220,226     $ 20 $ 2 918,190 (6) (697,980)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon vesting of restricted stock units (in shares)       787,223        
Stock-based compensation 2,565         2,565    
Net unrealized gain (loss) on marketable securities, net of tax (304)           (304)  
Foreign currency translation (72)           (72)  
Net loss (21,671)             (21,671)
Balance (in shares) at Mar. 31, 2026       197,218,496 19,937,500      
Balance at Mar. 31, 2026 200,744     $ 20 $ 2 920,755 (382) (719,651)
Balance (in shares) at Dec. 31, 2025   196,431,273 19,937,500 196,431,273 19,937,500      
Balance at Dec. 31, 2025 220,226     $ 20 $ 2 918,190 (6) (697,980)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net unrealized gain (loss) on marketable securities, net of tax (341)              
Foreign currency translation (94)              
Net loss (45,205)              
Balance (in shares) at Jun. 30, 2026   198,946,412 19,937,500 198,946,412 19,937,500      
Balance at Jun. 30, 2026 180,201     $ 20 $ 2 923,805 (441) (743,185)
Balance (in shares) at Mar. 31, 2026       197,218,496 19,937,500      
Balance at Mar. 31, 2026 200,744     $ 20 $ 2 920,755 (382) (719,651)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued upon vesting of restricted stock units (in shares)       1,727,916        
Stock-based compensation 3,050         3,050    
Net unrealized gain (loss) on marketable securities, net of tax (37)           (37)  
Foreign currency translation (22)           (22)  
Net loss (23,534)             (23,534)
Balance (in shares) at Jun. 30, 2026   198,946,412 19,937,500 198,946,412 19,937,500      
Balance at Jun. 30, 2026 $ 180,201     $ 20 $ 2 $ 923,805 $ (441) $ (743,185)